Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MDXH MDxHealth
3.890-2.120-35.27%
Close
02/03 16:00 ET
3.840-0.050-1.29%
Post Mkt Price 02/03 19:56 ET
High
3.990
Open
3.890
Turnover
9.46M
Low
3.600
Pre Close
6.010
Volume
2.48M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Top Midday Decliners
02:16 PM EST, 02/03/2023 (MT Newswires) -- Edible Garden AG (EDBL) said Thursday it priced an upsized offering of about 1.6 million units at $6.30 apiece for gross proceeds of about $10.2 million. The
QBTS, BBAI and ATTO Among Mid-day Movers
ReShape, Genetic Top Healthcare Gainers; MDxHealth, Summit Lead Losers' Pack
Ford Motor, Atlassian, Bill.com Among Premarket Losers' Pack
MDxHealth Prices $40 Million Public Offering of American Depositary Shares
08:45 AM EST, 02/03/2023 (MT Newswires) -- MDxHealth (MDXH.BR) on Friday priced the public offering of 10 million American Depositary Shares at $4 apiece to raise gross proceeds of $40 million. The Eu
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersGenetic Technologies (NASDAQ:GENE) shares increased by 175.2% to $2.78 during Friday's pre-market session. The company's market cap stands at $42.7 million. Reshape Lifesciences (NASDAQ:RSLS) s
MDxHealth To Use Proceeds for General Corporate and Working Cap Purposes >MDXH.BT
MDxHealth To Use Proceeds for General Corporate and Working Cap Purposes >MDXH.BT
MDxHealth Announces Pricing of Offering of ADSs in the United States
NEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET MDxHealth Announces Pricing of Offering of ADSsin the United States IRVINE, CA, and HERSTAL, BELGIUM – Feb
MDxHealth Prices Offering of 10M ADS at $4 Each >MDXH.BT
MDxHealth Prices Offering of 10M ADS at $4 Each >MDXH.BT
Top Premarket Decliners
07:49 AM EST, 02/03/2023 (MT Newswires) -- Edible Garden (EDBL) shares slumped 43% premarket Friday, a day after the company priced a $10.2 million public offering of common stock and warrants. Gaucho
Company Overview
More
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
CEO： Mr. Michael K. McGarrity
Market： NASDAQ
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet